{"id":"https://openalex.org/W7123342963","doi":"https://doi.org/10.2147/cmar.s564913","title":"Taxanes Versus Pemetrexed After Osimertinib Resistance in EGFR-Mutated NSCLC: A Retrospective Cohort with Two-Model In Vitro Validation","display_name":"Taxanes Versus Pemetrexed After Osimertinib Resistance in EGFR-Mutated NSCLC: A Retrospective Cohort with Two-Model In Vitro Validation","alternate_titles":[],"publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7123342963","doi":"https://doi.org/10.2147/cmar.s564913","pmid":"https://pubmed.ncbi.nlm.nih.gov/41940256","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13047780"},"language":"en","primary_location":{"id":"doi:10.2147/cmar.s564913","doi":"https://doi.org/10.2147/cmar.s564913","is_oa":true,"landing_page_url":"https://doi.org/10.2147/cmar.s564913","pdf_url":"https://www.dovepress.com/article/download/110940","source":{"id":"https://openalex.org/S2764554612","display_name":"Cancer Management and Research","issn_l":"1179-1322","issn":["1179-1322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Management and Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7123342963"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/article/download/110940","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159874745","display_name":"Ning Yang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ning Yang","raw_affiliation_strings":["Department of Oncology, General Hospital of Southern Theater Command, Guangzhou, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, General Hospital of Southern Theater Command, Guangzhou, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122845245","display_name":"Ning Wan","orcid":"https://orcid.org/0000-0001-8876-626X","observed_orcids":["https://orcid.org/0000-0001-8876-626X"]},"institutions":[{"id":"https://openalex.org/I58200834","display_name":"Southern Medical University","ror":"https://ror.org/01vjw4z39","country_code":"CN","type":"education","lineage":["https://openalex.org/I58200834"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ning Wan","raw_affiliation_strings":["Department of Clinical Pharmacy, General Hospital of Southern Theater Command, Guangzhou, People's Republic of China","School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China"],"raw_orcid":"https://orcid.org/0000-0001-8876-626X","affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, General Hospital of Southern Theater Command, Guangzhou, People's Republic of China","institution_ids":[]},{"raw_affiliation_string":"School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China","institution_ids":["https://openalex.org/I58200834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122865452","display_name":"Ya Guo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I58200834","display_name":"Southern Medical University","ror":"https://ror.org/01vjw4z39","country_code":"CN","type":"education","lineage":["https://openalex.org/I58200834"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ya Guo","raw_affiliation_strings":["Department of Clinical Pharmacy, General Hospital of Southern Theater Command, Guangzhou, People's Republic of China","School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, General Hospital of Southern Theater Command, Guangzhou, People's Republic of China","institution_ids":[]},{"raw_affiliation_string":"School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China","institution_ids":["https://openalex.org/I58200834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122861316","display_name":"Lijuan Xiong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I117532281","display_name":"Guangzhou University of Chinese Medicine","ror":"https://ror.org/03qb7bg95","country_code":"CN","type":"education","lineage":["https://openalex.org/I117532281"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lijuan Xiong","raw_affiliation_strings":["Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China","institution_ids":["https://openalex.org/I117532281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159927974","display_name":"Xiting Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I117532281","display_name":"Guangzhou University of Chinese Medicine","ror":"https://ror.org/03qb7bg95","country_code":"CN","type":"education","lineage":["https://openalex.org/I117532281"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiting Chen","raw_affiliation_strings":["Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China","institution_ids":["https://openalex.org/I117532281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122893336","display_name":"Dou Du","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I117532281","display_name":"Guangzhou University of Chinese Medicine","ror":"https://ror.org/03qb7bg95","country_code":"CN","type":"education","lineage":["https://openalex.org/I117532281"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dou Du","raw_affiliation_strings":["Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China","institution_ids":["https://openalex.org/I117532281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5129470957","display_name":"Bo Xie","orcid":"https://orcid.org/0000-0002-1529-393X","observed_orcids":["https://orcid.org/0000-0002-1529-393X"]},"institutions":[{"id":"https://openalex.org/I117532281","display_name":"Guangzhou University of Chinese Medicine","ror":"https://ror.org/03qb7bg95","country_code":"CN","type":"education","lineage":["https://openalex.org/I117532281"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Bo Xie","raw_affiliation_strings":["Department of Oncology, General Hospital of Southern Theater Command, Guangzhou, People's Republic of China","Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China"],"raw_orcid":"https://orcid.org/0000-0002-1529-393X","affiliations":[{"raw_affiliation_string":"Department of Oncology, General Hospital of Southern Theater Command, Guangzhou, People's Republic of China","institution_ids":[]},{"raw_affiliation_string":"Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China","institution_ids":["https://openalex.org/I117532281"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5122863714","display_name":"Juan Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I117532281","display_name":"Guangzhou University of Chinese Medicine","ror":"https://ror.org/03qb7bg95","country_code":"CN","type":"education","lineage":["https://openalex.org/I117532281"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Juan Zhou","raw_affiliation_strings":["Department of Oncology, General Hospital of Southern Theater Command, Guangzhou, People's Republic of China","Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, General Hospital of Southern Theater Command, Guangzhou, People's Republic of China","institution_ids":[]},{"raw_affiliation_string":"Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China","institution_ids":["https://openalex.org/I117532281"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5122863714","https://openalex.org/A5129470957"],"corresponding_institution_ids":["https://openalex.org/I117532281"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"Volume 18","issue":null,"first_page":"1","last_page":"13"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-mutant-non-small-cell-lung-cancer","display_name":"EGFR-mutant non-small cell lung cancer","score":0.8840000033378601},{"id":"https://openalex.org/keywords/osimertinib-resistance","display_name":"osimertinib resistance","score":0.9860000014305115},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.8690000176429749},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.9980000257492065},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9070000052452087},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9800000190734863},{"id":"https://openalex.org/keywords/chemosensitivity","display_name":"chemosensitivity","score":0.8100000023841858},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.6549999713897705},{"id":"https://openalex.org/keywords/non-hematologic-toxicity","display_name":"non-hematologic toxicity","score":0.8109999895095825},{"id":"https://openalex.org/keywords/in-vitro-drug-sensitivity-assay","display_name":"in vitro drug sensitivity assay","score":0.4869999885559082}],"concepts":[{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.9074000120162964},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7870000004768372},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7577000260353088},{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.7343999743461609},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6938999891281128},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6000999808311462},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5371999740600586},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5339000225067139},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4830999970436096},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4555000066757202},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.43790000677108765},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.3937999904155731},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33149999380111694},{"id":"https://openalex.org/C2777930144","wikidata":"https://www.wikidata.org/wiki/Q25100112","display_name":"T790M","level":5,"score":0.328900009393692},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.32420000433921814},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.31209999322891235},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.29429998993873596},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.2906999886035919},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.287200003862381},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2847999930381775},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2540999948978424}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.2147/cmar.s564913","doi":"https://doi.org/10.2147/cmar.s564913","is_oa":true,"landing_page_url":"https://doi.org/10.2147/cmar.s564913","pdf_url":"https://www.dovepress.com/article/download/110940","source":{"id":"https://openalex.org/S2764554612","display_name":"Cancer Management and Research","issn_l":"1179-1322","issn":["1179-1322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Management and Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13047780","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13047780/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13047780/pdf/CMAR-18-564913.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Manag Res","raw_type":"Text"},{"id":"pmid:41940256","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41940256","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer management and research","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:75a1195adfbd4d9bb1e3647f4dc8affd","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/75a1195adfbd4d9bb1e3647f4dc8affd","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Management and Research, Vol Volume 18, Iss Issue 1, Pp 1-13 (2026)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/110940","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/taxanes-versus-pemetrexed-after-osimertinib-resistance-in-egfr-mutated-peer-reviewed-fulltext-article-CMAR","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/cmar.s564913","doi":"https://doi.org/10.2147/cmar.s564913","is_oa":true,"landing_page_url":"https://doi.org/10.2147/cmar.s564913","pdf_url":"https://www.dovepress.com/article/download/110940","source":{"id":"https://openalex.org/S2764554612","display_name":"Cancer Management and Research","issn_l":"1179-1322","issn":["1179-1322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Management and Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7123342963.pdf","grobid_xml":"https://content.openalex.org/works/W7123342963.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W1994539763","https://openalex.org/W2099725888","https://openalex.org/W2551592805","https://openalex.org/W2734973978","https://openalex.org/W2739029233","https://openalex.org/W2797700531","https://openalex.org/W2945297162","https://openalex.org/W2979407281","https://openalex.org/W2990041408","https://openalex.org/W3006347594","https://openalex.org/W3013493241","https://openalex.org/W3137711059","https://openalex.org/W3150192782","https://openalex.org/W3204380660","https://openalex.org/W4255328688","https://openalex.org/W4311677159","https://openalex.org/W4313454050","https://openalex.org/W4362676414","https://openalex.org/W4366822282","https://openalex.org/W4366992637","https://openalex.org/W4372214946","https://openalex.org/W4390946922","https://openalex.org/W4391233288","https://openalex.org/W4391520930","https://openalex.org/W4392183706","https://openalex.org/W4396616739","https://openalex.org/W4396955535","https://openalex.org/W4400344157","https://openalex.org/W4400379220","https://openalex.org/W4402886999","https://openalex.org/W4404167741","https://openalex.org/W4404839476","https://openalex.org/W4408404573","https://openalex.org/W4409119860","https://openalex.org/W4413572801"],"related_works":["https://openalex.org/W4404704376","https://openalex.org/W4402737681","https://openalex.org/W4399696683","https://openalex.org/W4385773908","https://openalex.org/W4415295904","https://openalex.org/W2945297162","https://openalex.org/W3014296559","https://openalex.org/W4388484248","https://openalex.org/W4403412630","https://openalex.org/W4401653251"],"abstract_inverted_index":{"Purpose:":[0],"To":[1],"evaluate":[2],"whether":[3],"chemotherapy":[4,32,43,218],"backbone":[5],"selection":[6],"influences":[7],"outcomes":[8,119,224],"in":[9,61,124,165,227,242],"epidermal":[10],"growth":[11],"factor":[12,164],"receptor":[13],"(EGFR)\u2011mutated":[14],"non-small":[15],"cell":[16],"lung":[17],"cancer":[18],"(NSCLC)":[19],"after":[20,230],"acquired":[21],"resistance":[22],"to":[23,210],"osimertinib,":[24],"addressing":[25],"the":[26,116,125],"absence":[27],"of":[28],"a":[29],"preferred":[30],"post\u2011osimertinib":[31],"approach.":[33],"Methods:":[34],"Outcomes":[35],"were":[36,120,129,189],"retrospectively":[37],"compared":[38,64],"between":[39,66],"taxane\u2011based":[40],"and":[41,48,69,97,144,179],"pemetrexed\u2011based":[42],"using":[44],"propensity":[45],"score":[46],"matching":[47],"multivariable":[49],"Cox":[50],"models;":[51],"progression":[52,167,229],"was":[53,219],"stratified":[54],"as":[55,160],"gradual":[56],"or":[57],"dramatic.":[58],"An":[59],"exploratory":[60,241],"vitro":[62,243],"assay":[63],"chemosensitivity":[65],"osimertinib\u2011resistant":[67,202],"sublines":[68,203],"parental":[70,213],"cells.":[71],"Results:":[72],"After":[73],"1:1":[74],"matching,":[75],"taxanes":[76,128,159,193,211],"showed":[77],"numerically":[78],"longer":[79,132],"progression\u2011free":[80],"survival":[81,99],"(PFS;":[82],"median":[83],"8.8":[84],"vs":[85,102,135,147,198],"7.9":[86],"months;":[87,104,137,149],"hazard":[88,171],"ratio":[89,172],"[HR]:":[90],"0.71,":[91],"95%":[92,107,140,152,175,183],"confidence":[93],"interval":[94],"[CI]:":[95],"0.48-1.03)":[96],"overall":[98],"(OS;":[100],"18.8":[101],"15.9":[103],"HR:":[105,138,150],"0.70,":[106],"CI:":[108,141,153,176,184],"0.45-1.09)":[109],"versus":[110,212],"pemetrexed,":[111],"without":[112],"statistical":[113],"significance.":[114],"In":[115],"gradual\u2011progression":[117],"cohort,":[118,127],"comparable.":[121],"By":[122],"contrast,":[123],"dramatic\u2011progression":[126],"associated":[130,220],"with":[131,192,221,233],"PFS":[133,169],"(7.7":[134],"6.4":[136],"0.51,":[139,182],"0.30-0.86;":[142],"P=0.009)":[143],"OS":[145,180],"(16.1":[146],"12.7":[148],"0.54,":[151],"0.30-0.97;":[154],"P=0.034).":[155],"Multivariable":[156],"analysis":[157],"identified":[158],"an":[161],"independent":[162],"favorable":[163,223],"dramatic":[166,228],"for":[168],"(adjusted":[170],"[aHR]:":[173],"0.48,":[174],"0.27-0.84;":[177],"P=0.011)":[178],"(aHR:":[181],"0.27-0.96;":[185],"P=0.036).":[186],"Non\u2011hematologic":[187],"toxicities":[188],"more":[190,222],"frequent":[191],"than":[194,225],"pemetrexed":[195,226],"(56/74,":[196],"75.7%":[197],"52/95,":[199],"54.7%).":[200],"Additionally,":[201],"exhibited":[204],"reduced":[205],"half-maximal":[206],"inhibitory":[207],"concentration":[208],"(IC50)":[209],"cells":[214],"(P<0.05).":[215],"Conclusion:":[216],"Taxane\u2011based":[217],"osimertinib":[231],"resistance,":[232],"higher":[234],"non\u2011hematologic":[235],"toxicity.":[236],"These":[237],"findings,":[238],"supported":[239],"by":[240],"sensitivity,":[244],"warrant":[245],"prospective":[246],"validation.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7123342963","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2026-01-14T00:00:00"}
